Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001190
Filing Date
2025-03-28
Accepted
2025-03-28 16:10:22
Documents
55
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1121052
2 ex23-1.htm EX-23.1 3652
3 ex31-1.htm EX-31.1 15790
4 ex31-2.htm EX-31.2 15765
5 ex32-1.htm EX-32.1 6292
6 ex32-2.htm EX-32.2 6261
  Complete submission text file 0001641172-25-001190.txt   3767184

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inti-20241231.xsd EX-101.SCH 21646
8 XBRL CALCULATION FILE inti-20241231_cal.xml EX-101.CAL 35465
9 XBRL DEFINITION FILE inti-20241231_def.xml EX-101.DEF 93138
10 XBRL LABEL FILE inti-20241231_lab.xml EX-101.LAB 254090
11 XBRL PRESENTATION FILE inti-20241231_pre.xml EX-101.PRE 203651
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 293411
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 25786085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)